Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) FCF Margin (2024 - 2025)

Zenas BioPharma (ZBIO) has 2 years of FCF Margin data on record, last reported at 370.69% in Q1 2025.

  • For Q1 2025, FCF Margin changed N/A year-over-year to 370.69%; the TTM value through Sep 2025 reached 1057.1%, changed N/A, while the annual FY2024 figure was 2396.1%, 233501.0% down from the prior year.
  • FCF Margin reached 370.69% in Q1 2025 per ZBIO's latest filing, up from 772.56% in the prior quarter.
  • Across five years, FCF Margin topped out at 370.69% in Q1 2025 and bottomed at 772.56% in Q4 2024.